Cargando…

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain

Viral protein 35 (VP35) of Ebola virus (EBOV) is a multifunctional protein that mainly acts as a viral polymerase cofactor and an interferon antagonist. VP35 interacts with the viral nucleoprotein (NP) and double-stranded RNA for viral RNA transcription/replication and inhibition of type I interfero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasajima, Nodoka, Matsuno, Keita, Miyamoto, Hiroko, Kajihara, Masahiro, Igarashi, Manabu, Takada, Ayato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618116/ https://www.ncbi.nlm.nih.gov/pubmed/34835122 http://dx.doi.org/10.3390/v13112316

Ejemplares similares

Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor
por: Kondoh, Tatsunari, et al.
Publicado: (2017)

The Unique Phylogenetic Position of a Novel Tick-Borne Phlebovirus Ensures an Ixodid Origin of the Genus Phlebovirus
por: Matsuno, Keita, et al.
Publicado: (2018)

Single Nucleotide Variants of the Human TIM-1 IgV Domain with Reduced Ability to Promote Viral Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
por: Haasnoot, Joost, et al.
Publicado: (2007)

Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein
por: Lombe, Boniface Pongombo, et al.
Publicado: (2022)

The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs
por: Mitchell, William M, et al.
Publicado: (2014)

Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus
por: Becquart, Pierre, et al.
Publicado: (2014)

Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
por: Mirza, Muhammad Usman, et al.
Publicado: (2016)

Serological Evidence of Ebola Virus Infection in Indonesian Orangutans
por: Nidom, Chairul A., et al.
Publicado: (2012)

Ebola virus VP35 has novel NTPase and helicase-like activities
por: Shu, Ting, et al.
Publicado: (2019)

A cryptic pocket in Ebola VP35 allosterically controls RNA binding
por: Cruz, Matthew A., et al.
Publicado: (2022)

Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection
por: Furuyama, Wakako, et al.
Publicado: (2016)

Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly
por: van Tol, Sarah, et al.
Publicado: (2022)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

Receptor-Mediated Host Cell Preference of a Bat-Derived Filovirus, Lloviu Virus
por: Takadate, Yoshihiro, et al.
Publicado: (2020)

Fatal Tickborne Phlebovirus Infection in Captive Cheetahs, Japan
por: Matsuno, Keita, et al.
Publicado: (2018)

Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition
por: Di Palma, Francesco, et al.
Publicado: (2019)

Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
por: Darko, Louis K. S., et al.
Publicado: (2021)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
por: Saito, Takeshi, et al.
Publicado: (2020)

Generation of bat-derived influenza viruses and their reassortants
por: Sato, Masahiro, et al.
Publicado: (2019)

Genetic Predisposition To Acquire a Polybasic Cleavage Site for Highly Pathogenic Avian Influenza Virus Hemagglutinin
por: Nao, Naganori, et al.
Publicado: (2017)

Characterization of the glycoproteins of bat-derived influenza viruses
por: Maruyama, Junki, et al.
Publicado: (2016)

Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus
por: Saito, Takeshi, et al.
Publicado: (2022)

The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing
por: Dilley, Kari A., et al.
Publicado: (2017)

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity
por: Flego, Michela, et al.
Publicado: (2019)

Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
por: Zhu, Lin, et al.
Publicado: (2022)

Ebola and Marburg virus VP35 coiled-coil validated as antiviral target by tripartite split-GFP complementation
por: Zinzula, Luca, et al.
Publicado: (2022)

Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism
por: Seesuay, Watee, et al.
Publicado: (2018)

Human Parainfluenza Virus 3 Phosphoprotein Is a Tetramer and Shares Structural and Interaction Features with Ebola Phosphoprotein VP35
por: Rodriguez Galvan, Joaquin, et al.
Publicado: (2021)

Influenza A Virus M2 Protein: Roles from Ingress to Egress
por: Manzoor, Rashid, et al.
Publicado: (2017)

A polymorphism of the TIM-1 IgV domain: Implications for the susceptibility to filovirus infection
por: Kuroda, Makoto, et al.
Publicado: (2014)

A Single Amino Acid in the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian Influenza Virus Strains
por: Nao, Naganori, et al.
Publicado: (2015)

Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling
por: Fanunza, Elisa, et al.
Publicado: (2018)

Ebola Virus VP35 Interacts Non-Covalently with Ubiquitin Chains to Promote Viral Replication Creating New Therapeutic Opportunities
por: Rodríguez-Salazar, Carlos A., et al.
Publicado: (2023)

A Key Hydrophobic Patch Identified in an AAA(+) Protein Essential for Its In Trans Inhibitory Regulation
por: Zhang, Nan, et al.
Publicado: (2013)

Clinical Evaluation of QuickNavi(TM)-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo
por: Makiala, Sheila, et al.
Publicado: (2019)

Comparison of Antiviral Activity between IgA and IgG Specific to Influenza Virus Hemagglutinin: Increased Potential of IgA for Heterosubtypic Immunity
por: Muramatsu, Mieko, et al.
Publicado: (2014)

Membrane binding and bending in Ebola VP40 assembly and egress
por: Stahelin, Robert V.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tdpogjaesfgt8im2k4r2c0skv2